Novavax And Serum Institute Of India Receive Emergency Use Authorization For COVID-19 Vaccine In Indonesia
Novavax, Inc. (NASDAQ:NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world's
Novavax Files For COVID-19 Vaccine Authorization With Health Canada And Completes Submission For Rolling Review To European Medicines Agency
Novavax, Inc. (NASDAQ:NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the completion of its rolling submission to
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.
Novavax Rips Higher After Completing Regulatory Filing For Authorization Of COVID-19 Vaccine In UK
After a protracted delay, Novavax, Inc. (NASDAQ: NVAX) is finally making some headway with its COVID-19 vaccine candidate – NVXCoV2373.
Novavax Reports Filed For Authorization Of Its COVID-19 Vaccine In UK
Filing marks first protein-based COVID-19 vaccine submitted to MHRA for authorization
All modules required for regulatory review, including CMC data, are now complete
Submission based on Phase 3 data from ~45K
48 Biggest Movers From Yesterday
Gainers
Xiaobai Maimai Inc. (NASDAQ: HX) shares surged 98.4% to settle at $18.87 on Wednesday on above-average volume. The company on Tuesday disclosed the resignation of its CEO and Chairman and announced the appointment of Yilin Wang as CEO.
Mid-Day Market Update: Healthcare Services Drops After Q3 Results; Radius Health Shares Jump
Midway through trading Wednesday, the Dow traded up 0.40% to 35,598.89 while the NASDAQ rose 0.15% to 15,151.71. The S&P also rose, gaining 0.37% to 4,536.47.
Abbot Labs and Biogen Outshine Novavax in the Health Care Sector
Just before Tuesday’s close, Netflix (NASDAQ: NFLX) reported better-than-expected earnings by adding 4.4 million subscribers in the third quarter.